Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| Derived | EUR | Real-time | ||
| Xetra | EUR | Delayed | ||
| BATS Europe | EUR | Delayed | ||
| OTC Markets | USD | Delayed | ||
| London | EUR | Real-time | ||
| Mexico | MXN | Delayed | ||
| Milan | EUR | Real-time | ||
| Dusseldorf | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| Budapest | HUF | Delayed | ||
| Bucharest | RON | Delayed |
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Bayer AG (ETR:BAYGN) plans to spend $1 billion on drug research and development in the U.S. this year as it works to...
By Michael Erman and Patrick Wingrove NEW YORK (Reuters) – Bayer AG plans to spend $1 billion on drug research and development in the U.S. this year as it works to double its...
By Ludwig Burger FRANKFURT (Reuters) -Bayer warned operating earnings would decline in 2023, adding to the challenges for its new CEO who will take the helm in June, as the...
Bill Anderson has two qualifications for the job. He knows pharma. And he is American
German companies Bayer AG (DE:BAYN) and Beiersdorf AG (DE:BEI) will announce their annual results for 2022 this week. Analysts are impressed with Bayer's previous results and are...
Russian ruble plunge eases Gold advances US Treasury yields slide Key EventsAs a massive Russian convoy moves toward Ukraine's capital Kyiv on Tuesday, US futures on the Dow...
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
| Average | 74.90 (+33.68% Upside) |
| High | 99.00 |
| Low | 57.00 |
| Price | 56.03 |
| No. of Analysts | 21 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 154.40 | 157.00 | 153.40 | -0.80 | -0.52% | 3.74M | London | |||
| 207.50 | 210.00 | 200.00 | -4.50 | -2.12% | 2.97M | London | |||
| 136.36 | 138.04 | 128.16 | -3.20 | -2.29% | 146.66M | London | |||
| 1,000.00 | 990.00 | 960.00 | -15.00 | -1.48% | 48.22K | London | |||
| 99.80 | 100.75 | 98.26 | -1.40 | -1.38% | 22.35M | London | |||
| 203.00 | 210.00 | 197.40 | -0.50 | -0.25% | 257.16K | London | |||
| 0.146 | 0.152 | 0.146 | -0.0100 | -6.35% | 316.45M | London | |||
| 479.00 | 483.00 | 468.50 | -1.00 | -0.21% | 65.08K | London | |||
| 1,110.00 | 1,136.00 | 1,052.00 | +29.00 | +2.68% | 389.41K | London | |||
| 92.47 | 92.89 | 89.16 | +2.10 | +2.32% | 77.55M | London | |||
| 12.10 | 12.20 | 11.80 | -0.10 | -0.82% | 155.10K | London | |||
| 375.00 | 400.00 | 372.00 | -20.00 | -5.06% | 185.24K | London | |||
| 0.12 | 0.13 | 0.13 | 0.00 | 0.00% | 0.00 | Aquis Exchange | |||
| 271.90 | 279.00 | 262.80 | -2.50 | -0.91% | 1.26M | London | |||
| 1,130.00 | 1,140.00 | 1,122.00 | -8.00 | -0.70% | 154.78K | London |